Table 2.
ID | Status | Follow‐up month | Time to recurrence (month) | xCell ImmuneScore | Cytolytic activity score | ||
---|---|---|---|---|---|---|---|
Tumor‐free | Tumor | Tumor‐free | Tumor | ||||
p40 | DWD | 1 | 0.52 | 6.02 | |||
p42 | DWD | 9 | 7 | 0.16 | 5.14 | ||
p14 | ADF | 177 | 0.59 | 6.03 | |||
p24 | ADF | 168 | 0.74 | 6.98 | |||
p29 | DWD | 29 | 20 | 0.52 | 7.40 | ||
p68 | DOD | 9 | 6 | 0.44 | 7.16 | ||
p70 | ADF | 109 | 0.52 | 7.01 | |||
p82 | DOD | 18 | 12 | 0.60 | 7.12 | ||
p83 | ADF | 93 | 0.70 | 8.58 | |||
p92 | DOD | 20 | 6 | 0.73 | 7.54 | ||
p11 | DWD | 3 | 0.34 | 0.56 | 5.54 | 5.99 | |
p35 | DOD | 13 | 10 | 0.14 | 0.03 | 4.85 | 4.97 |
p49 | DWD | 3 | 0.16 | 0.54 | 5.29 | 7.16 | |
p51 | ADF | 132 | 0.26 | 0.45 | 5.37 | 5.95 | |
p56 | DOD | 16 | 12 | 0.78 | 0.17 | 8.26 | 5.67 |
p58 | ADF | 119 | 0.24 | 0.42 | 5.58 | 6.00 | |
p59 | DOD | 7 | 0.20 | 0.40 | 5.14 | 5.07 | |
p61 | DDF | 81 | 0.22 | 0.54 | 5.45 | 6.59 | |
p65 | ADF | 112 | 0.16 | 0.71 | 5.40 | 7.59 | |
p73 | DOD | 19 | 11 | 0.24 | 0.58 | 5.13 | 6.45 |
p76 | ADF | 103 | 0.25 | 0.52 | 5.49 | 5.92 | |
p79 | ADF | 108 | 0.34 | 0.51 | 5.67 | 6.52 | |
p85 | DOD | 2 | 2 | 0.31 | 0.57 | 5.54 | 7.88 |
p98 | ADF | 60 | 0.21 | 0.75 | 4.66 | 6.50 | |
p105 | ADF | 55 | 0.42 | 0.48 | 5.96 | 6.91 | |
p111 | ADF | 51 | 0.19 | 0.26 | 5.27 | 5.40 | |
p119 | ADF | 45 | 0.25 | 0.66 | 5.38 | 6.68 | |
p124 | DOD | 3 | 0.15 | 0.55 | 5.14 | 5.95 | |
p131 | ADF | 38 | 0.24 | 0.24 | 5.42 | 4.91 | |
p137 | ADF | 36 | 0.10 | 0.56 | 5.34 | 7.02 | |
p138 | ADF | 35 | 0.23 | 0.31 | 5.85 | 5.43 |
ADF, alive disease free; DDF, dead disease free; DOD, dead of disease; DWD, dead with disease.